The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
Eighty-third report of the Joint FAO/WHO Expert Committee on Food Additives
(2017)
______
Fonte: WHO
Raccomandazione (UE) 2022/495 della Commissione del 25 marzo 2022 relativa al monitoraggio della presenza di furano e di alchil furani negli alimenti
GU L 100/60 del 28.3.2...
ID 20306 | 02.09.2023
Linee guida sulla pubblicità sanitaria dei medicinali di automedicazione (OTC) e dei medicinali senza obbligo di pr...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
